13F HOLDINGS REPORT
Avoro Capital Advisors LLC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001104659-23-090901
Total Value
$7.37B
Positions
43
Other Managers
0
Confidential Omitted
No
Holdings (43)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APELLIS PHARMACEUTICALS INC | APLS | 11,111,111 | $1.01B | 13.73% |
| 2 | HORIZON THERAPEUTICS PLC | G46188101 | 7,000,000 | $720.0M | 9.77% |
| 3 | UNITED THERAPEUTICS CORP | UTHR | 2,909,999 | $642.4M | 8.71% |
| 4 | SAREPTA THERAPEUTICS INC | SRPT | 4,627,888 | $530.0M | 7.19% |
| 5 | ARGENX SE | ARGX | 1,263,500 | $492.4M | 6.68% |
| 6 | MADRIGAL PHARMACEUTICALS INC | MDGL | 1,515,151 | $350.0M | 4.75% |
| 7 | BIOMARIN PHARMACEUTICAL INC | BMRN | 4,000,000 | $346.7M | 4.70% |
| 8 | AMICUS THERAPEUTICS INC | FOLD | 27,400,000 | $344.1M | 4.67% |
| 9 | SEAGEN INC | SE | 1,759,606 | $338.7M | 4.59% |
| 10 | ASCENDIS PHARMA | ASND | 3,580,555 | $319.6M | 4.34% |
| 11 | IVERIC BIO INC | 46583P102 | 8,050,000 | $316.7M | 4.30% |
| 12 | KRYSTAL BIOTECH INC | KRYS | 2,560,811 | $300.6M | 4.08% |
| 13 | ALNYLAM PHARMACEUTICALS INC | ALNY | 1,105,000 | $209.9M | 2.85% |
| 14 | MIRATI THERAPEUTICS INC | 60468T105 | 5,555,555 | $200.7M | 2.72% |
| 15 | XENON PHARMACEUTICALS INC | XENE | 4,900,000 | $188.7M | 2.56% |
| 16 | CYMABAY THERAPEUTICS INC | 23257D103 | 10,300,000 | $112.8M | 1.53% |
| 17 | DICE THERAPEUTICS INC | 23345J104 | 2,199,342 | $102.2M | 1.39% |
| 18 | KYMERA THERAPEUTICS INC | KYMR | 3,855,000 | $88.6M | 1.20% |
| 19 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 1,725,000 | $88.0M | 1.19% |
| 20 | BIOCRYST PHARMACEUTICALS INC | BCRX | 12,055,000 | $84.9M | 1.15% |
| 21 | NUVALENT INC | NUVL | 1,600,000 | $67.5M | 0.92% |
| 22 | ROIVANT SCIENCES LTD | ROIV | 5,806,162 | $58.5M | 0.79% |
| 23 | SYNDAX PHARMACEUTICALS INC | SNDX | 2,650,000 | $55.5M | 0.75% |
| 24 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 6,700,000 | $47.2M | 0.64% |
| 25 | MANNKIND CORP | MNKD | 9,100,000 | $37.0M | 0.50% |
| 26 | ULTRAGENYX PHARMACEUTICAL INC | RARE | 750,000 | $34.6M | 0.47% |
| 27 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 3,150,000 | $34.2M | 0.46% |
| 28 | KURA ONCOLOGY INC | KURA | 3,105,000 | $32.9M | 0.45% |
| 29 | MONTE ROSA THERAPEUTICS INC | GLUE | 4,535,000 | $31.1M | 0.42% |
| 30 | AVIDITY BIOSCIENCES INC | 05370A108 | 2,510,000 | $27.8M | 0.38% |
| 31 | DESIGN THERAPEUTICS INC | DSGN | 3,500,000 | $22.1M | 0.30% |
| 32 | MERSANA THERAPEUTICS INC | 59045L106 | 6,375,000 | $21.0M | 0.28% |
| 33 | AADI BIOSCIENCES INC | WHWK | 2,849,402 | $19.5M | 0.26% |
| 34 | PMV PHARMACEUTICALS INC | PMVP | 3,060,000 | $19.2M | 0.26% |
| 35 | VERRICA PHARMACEUTICALS INC | VRCA | 2,954,064 | $17.0M | 0.23% |
| 36 | ARROWHEAD PHARMACEUTICALS INC | ARWR | 357,403 | $12.7M | 0.17% |
| 37 | SERES THERAPEUTICS INC | MCRB | 2,500,000 | $12.0M | 0.16% |
| 38 | IKENA ONCOLOGY INC | 45175G108 | 1,640,000 | $10.8M | 0.15% |
| 39 | FENNEC PHARMACEUTICALS INC | FENC | 1,200,000 | $10.6M | 0.14% |
| 40 | TANGO THERAPEUTICS INC | TNGX | 1,640,000 | $5.4M | 0.07% |
| 41 | IO BIOTECH INC | IOBT | 2,055,883 | $4.0M | 0.05% |
| 42 | TALARIS THERAPEUTICS INC | 87410C104 | 500,000 | $1.5M | 0.02% |
| 43 | AEGLEA BIOTHERAPEUTICS INC | 00773J103 | 286,459 | $129,050 | 0.00% |